Your browser doesn't support javascript.
loading
Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report.
Valet, Orion; Swalduz, Aurélie; Boussageon, Maxime; Buisson, Adrien; Avrillon, Virginie; Mastroïanni, Bénédicte; Pérol, Maurice.
Affiliation
  • Valet O; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Swalduz A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Boussageon M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Buisson A; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Avrillon V; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Mastroïanni B; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Pérol M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
JTO Clin Res Rep ; 2(6): 100192, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34590033
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JTO Clin Res Rep Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JTO Clin Res Rep Year: 2021 Document type: Article Affiliation country: Country of publication: